a:3:{s:6:"_token";s:40:"XbXUFQiWKuHSEAfoCvo9A8TzHo7GUhTEbfxKn1Gp";s:9:"_previous";a:1:{s:3:"url";s:188:"https://www.pharmafocusasia.com/pressreleases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-colorectal-cancer-at-asco-gi-2024";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}